
NASDAQ:KLDO • US4833471000
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KALEIDO BIOSCIENCES INC (KLDO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-01-31 | Chardan Capital | Maintains | Buy |
| 2021-11-12 | Chardan Capital | Maintains | Buy |
| 2021-11-03 | JMP Securities | Maintains | Market Outperform |
| 2021-10-19 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2021-03-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-09 | Piper Sandler | Initiate | Overweight |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 980K | 1.104M 12.65% | 543.997K -50.72% | 21.712M 3,891.29% | 53.217M 145.10% | 133.042M 150.00% | ||
| EBITDA YoY % growth | -85.34M -42.49% | -77.05M 9.71% | -85.309M -10.72% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -86.66M -42.81% | -78.87M 8.99% | -87.667M -11.15% | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | -8,047.96% | -7,940.85% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -3.74 | -2.44 34.76% | N/A 5.45% | -2.07 10.24% | -1.86 10.34% | -2.01 -8.13% | -2.21 -10.29% |
| Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.49 16.03% | -0.39 29.88% | -0.39 28.22% | -0.39 34.48% | -0.40 18.32% | -0.41 -5.19% | -0.40 -2.63% | -0.40 -3.95% |
| Revenue Q2Q % growth | 63.75K -78.75% | 63.75K -69.79% | 63.75K -38.70% | 63.75K -87.04% | 6.86M 10,660.00% | 6.86M 10,660.00% | 6.86M 10,660.00% | 6.86M 10,660.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 analysts have analysed KLDO and the average price target is 11.91 null. This implies a price increase of 4006.38% is expected in the next year compared to the current price of 0.29.
KALEIDO BIOSCIENCES INC (KLDO) will report earnings on 2022-05-02.
The consensus EPS estimate for the next earnings of KALEIDO BIOSCIENCES INC (KLDO) is -0.49 null and the consensus revenue estimate is 63.75K null.
The number of analysts covering KALEIDO BIOSCIENCES INC (KLDO) is 12.